ESC 365 - Smooth muscle cell-specific deletion of S100A4 modifies smooth muscle cell fate and inflammation in murine atherosclerotic lesions

FCVB 2024 Premium Access

Smooth muscle cell-specific deletion of S100A4 modifies smooth muscle cell fate and inflammation in murine atherosclerotic lesions

Session: Young Investigator Award I

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor P. Azar (Geneva, CH)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

About the speaker

Doctor Pascal Azar

University of Geneva, Geneva (Switzerland)

0 follower

3 more presentations in this session

Role of ADAR2-mediated innate immune responses in vascular inflammation and atherosclerosis

Speaker: Doctor M. Amponsah-Offeh (Mannheim, DE)

Exploring the interactions between cardiomyocytes and endothelial cells to induce cardiac revascularization and regeneration

Speaker: Mr R. Vuerich (Trieste, IT)

Targeting the histone methyltransferase SETD7 rescues diabetes-induced impairment of angiogenic response by transcriptional repression of semaphorin 3G

Speaker: Doctor S. Mohammed (Zurich, CH)

Access the full session

Young Investigator Award I

Speakers: Doctor P. Azar, Doctor M. Amponsah-Offeh, Mr R. Vuerich, Doctor S. Mohammed

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by